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Abstract
Purpose Cardiovascular disease (CVD) is a leading cause of mortality globally and is strongly influenced by dietary risk 
factors. The aim was to assess the association between egg consumption and risk of CVD risk/mortality, including coronary 
heart disease (CHD), stroke, and heart failure.
Methods MEDLINE, Embase, and Web of Science databases were searched through April 2020 for prospective studies. 
Two independent reviewers screened and extracted the data through standardized methods. Size effects were calculated as 
summary relative risks (SRRs) in a dose–response fashion through random-effects meta-analyses.
Results Thirty-nine studies including nearly 2 million individuals and 85,053 CHD, 25,103 stroke, 7536 heart failure, 
and 147,124 CVD cases were included. The summary analysis including 17 datasets from 14 studies conducted on CVD 
(incidence and/or mortality) showed that intake of up to six eggs per week is inversely associated with CVD events, when 
compared to no consumption [for four eggs per week, SRR = 0.95 (95% CI: 0.90; 1.00)]; a decreased risk of CVD incidence 
was observed for consumption of up to one egg per day [SRR = 0.94 (95% CI: 0.89; 0.99)]. The summary analysis for CHD 
incidence/mortality including 24 datasets from 16 studies showed a decreased risk up to two eggs per week [(SRR = 0.96 
(95% CI: 0.91; 1.00)]. No associations were retrieved with risk of stroke. The summary analysis for heart failure risk includ-
ing six datasets from four studies showed that intake of one egg per day was associated with increased risk raising for higher 
intakes compared to no consumption [for 1 egg per day, SRR = 1.15 (95% CI:1.02; 1.30)]. After considering GRADE criteria 
for strength of the evidence, it was rated low for all outcomes but stroke, for which it was moderate (yet referring to no risk).
Conclusion There is no conclusive evidence on the role of egg in CVD risk, despite the fact that higher quality studies are 
warranted to obtain stronger evidence for a possible protection of CVD associated with moderate weekly egg consumption 
compared to no intake; equally, future studies may strengthen the evidence for increased heart failure risk associated with 
high regular egg consumption.
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Introduction
Cardiovascular disease (CVD) represents the leading cause 
of mortality globally, responsible for a total of about 18 
million deaths in 2017, while increasing from 12.3 million 
in 1990 [1]. Nutritional risk factors have been considered 
of paramount importance to prevent the global burden of 
CVD [2,3]. Among the many factors widely studied over 
the last decades, dietary cholesterol has been the focus of 
major attention due to the relationship between blood cho-
lesterol and increased risk of CVD firstly observed in the 
Framingham Heart Study nearly half century ago and ever 
since considered as risk factor [4]. Eggs, as major sources 
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of dietary cholesterol (200–300 mg/100 g, about 180 mg 
per medium egg), have been subsequently advised to be 
consumed in moderation to lower dietary cholesterol intake 
[5]. However, current evidence on the association between 
dietary cholesterol and CVD risk is not consistent [6]. In 
2000 the American Heart Association advised consumption 
of up to one egg per day [7] and nearly 10 years later the US 
Dietary Guidelines Advisory Committee eliminated choles-
terol restrictions from the latest US dietary guidelines [8]. 
Nonetheless, the general opinion on egg consumption might 
be misled and food advertising and media campaigns spon-
soring and claiming cholesterol-free products as healthier 
(sometimes supplemented with added sugars) are common. 
As specifically for egg consumption, a comprehensive sum-
mary of evidence reported repeatedly null and contrast-
ing findings, suggesting that meta-analytic studies need to 
better investigate potential confounding effects of relevant 
variables (i.e., sex, geographical area, adjustment for health 
or dietary variables, etc.) [9]. However, more prospective 
cohort studies have been published so far: specifically, a later 
study involving 6 US cohorts showed that egg consump-
tion was associated with increased risk of CVD and that 
the detrimental cardiovascular effect of egg consumption 
was mainly driven by dietary cholesterol, once more sug-
gesting the need to limit eggs consumption. In light of such 
considerations, the aim of this study was to update current 
evidence on the association between egg consumption and 
CVD risk while assessing whether confounding factors may 
play a role in such relation.
Methods
Study design
The design, analysis, and reporting of this study followed 
the meta-analysis of Observational Studies in Epidemiol-
ogy (MOOSE) guidelines (ESM Table 1). A systematic 
search on PubMed (https ://www.ncbi.nlm.nih.gov/pubme 
d/), EMBASE (https ://www.embas e.com/), Web of Science 
(www.webof knowl edge.com) databases of studies pub-
lished up to April 2020 was performed with the following 
search strategy: “[(egg OR eggs) AND (coronary heart dis-
ease OR myocardial infarction OR ischemic heart disease 
OR ischemic heart disease OR coronary artery disease OR 
heart disease OR stroke OR cardiovascular disease OR heart 
failure)] AND (cohort OR prospective OR longitudinal OR 
follow-up)”. Studies were selected if they met the follow-
ing inclusion criteria: (i) they were conducted on general 
population of human adults (i.e., no patients recruited in 
hospitals); (ii) had a prospective design; (iii) evaluated asso-
ciations between egg intake and risk of CVD (fatal and non-
fatal), cardiovascular-related outcomes (such as coronary 
heart disease [CHD] and stroke, fatal and non-fatal), and 
heart failure; (iv) assessed and reported hazard ratios (HRs) 
or risk ratios (RRs) and their corresponding 95% CI for ≥ 3 
exposure categories (egg consumption) or provided HRs 
for increased intake of egg (as a continuous variable); and 
(v) provided a defined amount of egg consumption per cat-
egory of exposure (i.e., servings of eggs per day or week). 
Reference lists of studies of interest were also examined for 
any additional study not previously identified. If more than 
one study was conducted on the same cohort, only the data-
set including the larger number of individuals, the longest 
follow-up, or the most comprehensive data (i.e., number of 
cases and person-year for each category of exposure) was 
included on a case by case situation, depending on the analy-
sis performed (see below). We did not exclude studies based 
on language or publication date. All references were evalu-
ated by two independent reviewers (J.G., G.G.) with a third 
reviewer (A.M.) available in case of disagreement.
Data extraction
Data were abstracted by the two independent reviewers from 
each identified study using a standardized extraction form. 
The following information was collected: (i) first author 
name; (ii) year of publication; (iii) study cohort name and 
country; (iv) number, sex, and age (mean or range) of par-
ticipants; (v) follow-up period; (vi) endpoints and cases; 
(vii) distributions of cases and person-years, HRs and 95% 
CIs for all categories of exposure; (viii) covariates used in 
adjustments.
Risk of bias and quality assessment
Risk of bias was assessed using the Cochrane Risk of bias 
in Non-randomized Studies of Interventions (ROBINS-I) 
tool previously used in comprehensive meta-analyses with 
similar outcomes [10, 11]. The tool consists of the follow-
ing seven domains: (1) confounding, (2) selection of par-
ticipants, (3) measurement of the exposure, (4) misclassifi-
cation of exposure during follow-up, (5) missing data, (6) 
measurement of outcomes and (7) selective reporting. Two 
researchers (J.G. and A. M.) assessed the risk of bias inde-
pendently. Any disagreements were resolved by consensus 
or by consultation of a third researcher.
Outcomes
Outcomes evaluated in the analyses included total CVD, 
CHD, and stroke (including sub-types hemorrhagic and 
ischemic stroke) incidence and mortality. Also risk of heart 
failure incidence was assessed.
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Statistical analysis
When egg consumption was reported by ranges of intake, 
the midpoint of the range was used. When the highest cat-
egory was open-ended, we assumed the width of the cat-
egory to be the same as the adjacent category. When the 
lowest category was open-ended, we set the lower bound-
ary to zero. Two-stage random-effects dose–response 
meta-analysis was performed to examine linear and 
non-linear relationship between egg consumption and 
CVD outcomes. In the first stage the method reported 
by Greenland and Orsini (generalized least-squares, 
GLS) was used to calculate study-specific coefficients 
on the basis of results across categories of egg consump-
tion taking into account the correlation within each set 
of retrieved HRs [12,13]. Non-linear dose–response 
analysis was modeled using restricted cubic splines with 
three knots at fixed percentiles (25%, 50%, and 75%) 
of the distribution [14]. We combined the coefficients 
that had been estimated within each study by performing 
random-effects meta-analysis. In linear dose–response 
meta-analysis the method of DerSimonian and Laird was 
used and in non-linear dose–response meta-analysis the 
multivariate extension of the method of moments was 
used to estimate summary relative risks (SRRs). We cal-
culated an overall P value by testing that the two regres-
sion coefficients were simultaneously equal to zero. We 
then calculated a P value for non-linearity by testing that 
the coefficient of the second spline was equal to zero. 
A subgroup analysis was conducted for those studies 
providing risk measures by diabetic status. A number of 
sensitivity analyses were conducted to test stability of 
results, including (i) exclusion of one study at the time, 
(ii) exclusion of studies that did not report number of 
cases and person-years for each category of exposure, 
and (iii) stratifying studies by variables of interest (such 
as sex, geographical localization of the cohort, level of 
adjustment for body mass index [BMI], diabetic status, 
and other dietary factors, and study quality). To facili-
tate interpretation of the results and easy application for 
dietary advices for the general population, the analyses 
were provided in depth for arbitrarily defined doses, such 
as “habitual” (daily) egg consumption corresponding to 
one egg per day, and “moderate” (weekly) egg consump-
tion corresponding to four eggs per week. Publication 
bias was assessed with Egger’s regression test. Statistical 
heterogeneity between studies was assessed using the χ2 
test (defined as a P value less than 0.10) and quantified 
through the multivariate generalization of the I2 statis-
tic. All analyses were performed with R software version 
3.0.3, dosresmeta and mvmeta packages (Development 
Core Team, Vienna, Austria).
Grading of the evidence
The certainty of the evidence was assessed using the Grad-
ing of Recommendations, Assessment, Development, and 
Evaluation (GRADE) system [15]. Included observational 
studies started at low-certainty of evidence by default and 
then were downgraded or upgraded based on pre-specified 
criteria. Criteria to downgrade certainty included study limi-
tations (weight of studies showing risk of bias by ROBINS-
I), inconsistency (substantial unexplained inter-study hetero-
geneity, I2 ≥ 50% and Phet < 0.10), indirectness (presence of 
factors relating to the population, exposures and outcomes 
that limit generalizability), imprecision [95% CIs were wide 
or crossed a minimally important difference of 5% (SRR 
0.95–1.05) for all CVD outcomes] and publication bias [sig-
nificant evidence of small-study effects). Criteria to upgrade 
included a large effect size (SRR > 2 or SRR < 0.5 in the 
absence of plausible confounders], a dose–response gradient 
and attenuation by plausible confounding effects.
Results
Study characteristics
Out of 291 initial references identified, a total of 39 stud-
ies [16–54] were selected based on 38 cohorts providing 
data on CHD (1,831,038 individuals and 85,053 cases), 
stroke (761,962 individuals and 25,103 cases), heart failure 
(254,588 individuals and 7536 cases), and CVD (1,117,033 
individuals and 147,124 cases) outcomes (Fig. 1). A detailed 
description of the studies included is presented in Table 1. 
From the 38 individual cohorts, 16 were from North Amer-
ica, 9 from Europe, 9 from Asia and one from Iran, and 3 
multinational cohorts. One of the studies from North Amer-
ica included a pooled analysis of 6 US cohorts (pooled data 
was used in this meta-analysis). All studies had adequate 
follow-up to assess occurrence of the outcomes investigated 
(ranging from 3 to 32 years of mean follow-up). All studies 
scored moderate or serious risk of bias; a detailed descrip-
tion of judgment of potential risk of bias is given in the 
online supplementary materials (ESM Table 2). All but four 
studies [25, 28, 32, 34] provided full data of interest for bet-
ter risk estimation (number of cases and person-years for 
each category of exposure), most of studies reported analy-
ses adjusted for potential confounders investigated: among 
other dietary factors, besides total energy intake nearly 
always considered, also intake of other food groups (fruit/
vegetable, whole grains, meat), macronutrients (trans-fats, 
protein) and fiber have been considered. Subgroup analyses 
were conducted through sex- and diabetic-specific groups, 
including nine studies provided separate risk estimates for 
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male and female participants, and eight studies for diabetic 
participants.
Egg consumption and cardiovascular outcomes
The dose–response analyses for egg consumption and car-
diovascular outcomes are showed in Fig. 2. The summary 
analysis including 17 datasets from 14 studies conducted 
on CVD (incidence and/or mortality) showed that intake of 
up to six eggs per week is inversely associated with CVD 
events, when comparing to no consumption [SRR = 0.98 
(95% CI: 0.95; 1.00), SRR = 0.96 (95% CI: 0.91; 1.00), 
SRR = 0.95 (95% CI: 0.89; 1.00), SRR = 0.95 (95% CI: 
0.90; 1.00), SRR = 0.95 (95% CI: 0.91; 1.00), SRR = 0.96 
(95% CI: 0.92; 1.00) for 1, 2, 3, 4, 5, and six eggs per week, 
respectively; (I2 = 71.94%, Pheter < 0.001)] with no evidence 
of publication bias (PEgger = 0.772). The analysis restricted 
to CVD mortality showed wide confidence intervals while a 
decreased risk of CVD incidence was observed for consump-
tion of up to 1 egg per day (Table 2).
The summary analysis for CHD incidence/mortality 
including 24 datasets from 16 studies showed a decreased 
risk up to two eggs per week [SRR = 0.96 (95% CI: 0.91; 
1.00), I2 = 82.25%, Pheter < 0.001] compared to no con-
sumption, while higher intake was associated with no 
further reduced risk; no publication bias was detected 
(PEgger = 0.173). Distinction between studies on CHD inci-
dence or mortality showed that the associated reduced risk 
Fig. 1  Flow chart of study iden-
tification and selection process
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was referring to the former, yet with evidence of heterogene-
ity (Table 2).
The summary analysis for stroke including 22 datasets 
from 16 studies showed no related risks associated with 
any dose of egg consumption compared to no consumption, 
with lower SRRs for stroke mortality, though with large 
CIs (Table 2). Also, the analyses conducted on sub-types 
of stroke, despite investigated in a lower number of studies 
(eight studies on hemorrhagic and nine studies on ischemic 
stroke), showed null associations with egg consumption, yet 
with evidence of heterogeneity (Table 2).
The summary analysis for heart failure risk including 
six datasets from four studies showed that intake of one 
egg per day was associated with increased risk raising for 
higher intakes compared to no consumption [SRR = 1.15 
(95% CI:1.02; 1.30), SRR = 1.19 (95% CI: 1.04; 1.36), 
SRR = 1.23 (95% CI: 1.06; 1.44) for 7, 8, and nine eggs 
per week, respectively], with no evidence of heterogeneity 
(I2 = 37%) and no publication bias (PEgger = 0.630).
In the sensitivity analyses by excluding one study at 
the time, results were substantially unchanged (data not 
shown). Also in the sensitivity analyses excluding stud-
ies with no complete data on number of individuals and 
cases risk estimates associated to egg consumption were 
unchanged for CVD and heart failure, while no associa-
tions with CHD and stroke were detected (ESM Table 3); 
moreover, both ischemic and hemorrhagic stroke risk was 
Fig. 2  Graphical representation of dose–response association between egg intake and CVD, CHD, stroke and heart failure risk in prospective 
cohort studies
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reduced with up to one egg per day compared to no con-
sumption (ESM Table 3).
Subgroup analyses
The subgroup analysis including results on cohort restricted 
to diabetic individuals showed that the direction of the risk 
associated with egg consumption was substantially inverted 
for all outcomes (Table 3); among all of them, the risk of 
CVD incidence/mortality peaked up to one egg per day 
[SRR = 1.22 (95% CI: 1.08; 1.39), I2 = 63%)] compared to 
no consumption.
The subgroup analysis by sex revealed a different relation 
with risk of CVD, CHD, and heart failure in women than 
in men. Among women a decreased risk of all outcomes for 
consumption of 4 eggs per week [SRR = 0.89 (95% CI: 0.82; 
0.96), SRR = 0.89 (95% CI: 0.82; 0.98), and 0.84 (95% CI: 
0.71; 1.00), respectively] with no evidence of heterogeneity 
between studies was observed (Table 3). When consider-
ing consumption of one egg per day, only CVD risk was 
decreased in women [SRR = 0.90 (95% CI: 0.81; 1.00)], with 
no evidence of heterogeneity (I2 = 0%) (Table 3). No sig-
nificant associations were observed among men (Table 3).
Stratified analyses
Several stratified analyses have been performed to test the 
stability of results taking into consideration the geographical 
localization of the cohorts as well as the level of adjustment 
models and the quality of the studies included. The analyses 
have been considered for a moderate consumption (four eggs 
per week) and a habitual consumption (one egg per day). 
Concerning the intake of 4 eggs/week, the decreased risk 
of CVD was confirmed when restricting the analyses to the 
majority of better quality studies, such as those adjusting for 
BMI, other dietary factors, longer follow-up, larger sample 
size, including heart failure in the definition of CVD, and 
scoring moderate risk of bias (Table 4); other strata associ-
ated with a decreased risk of CVD where studies conducted 
in US cohorts. Similar associations were retrieved for risk 
of CHD, with a direction toward reduction when restricting 
the analysis to studies adjusting for other dietary factors, 
longer follow-up and low risk of bias (Table 4). No associa-
tion between moderate egg consumption and risk of stroke 
nor heart failure was found (Table 4).
Concerning the intake of 1 egg/day, the analysis resulted 
in a decreased risk of CVD when involving studies con-
ducted in Asia and adjusting for other dietary factors 
(Table 4); curiously, a decreased risk was also observed in 
studies not adjusting for diabetic status, which on the con-
trary was reported to potentially act as effect modifier toward 
the opposite direction. No associations were retrieved for 
CHD risk, while also the risk of stroke was reduced only 
when considering Asian cohorts and studies including more 
than 10,000 individuals (Table 4). Also risk of heart fail-
ure differed between strata, resulting higher in the analysis 
restricted to US cohorts with large sample size, adjusted for 
BMI but not for other dietary factors; no study with low risk 
of bias was available (Table 4).
Evaluation of the evidence
Table 5 provides an overview of the GRADE assessment 
for the association between consumption of eggs and each 
cardiovascular outcome. The level of evidence was rated 
generally low for all outcomes but stroke, for which was 
moderate.
Discussion
The present meta-analysis provided an updated overview 
on the association between egg consumption and CVD risk 
and mortality: compared to previous meta-analyses, we 
included the highest number of cohorts reviewed to date, 
several dose–response analyses for the investigated out-
comes, a detailed investigation for potential confounding 
factors by studying subgroups and stratifying the analyses, 
and we attempted an evaluation of the overall evidence. Pre-
vious meta-analyses reported rather mixed results, with no 
association with stroke risk [55], decreased risk of stroke 
and no association with CHD [56, 57], decreased risk of 
CHD [58], no association with CVD risk [59], increased 
risk of heart failure [60, 61],compared to these studies, our 
analysis is more complete and provides a general more in 
depth analysis of level of evidence. We generally found no 
strong association with either increased or decreased risk of 
cardiovascular outcomes following the habitual consumption 
of eggs (i.e., one egg per day compared to no intake), with 
exception of risk of heart failure, which resulted higher espe-
cially in men from US cohorts. In contrast, there are more 
consistent results regarding the association between mod-
erate egg consumption (i.e., four eggs per week compared 
to no intake) and lower risk of CVD, especially in spite of 
the stratified analyses involving higher quality studies, for 
which there was lower heterogeneity across results. Also 
when considering the findings from the stratified analyses, 
heterogeneity of the results between studies remained sig-
nificant and rather unexplained. We can hypothesize that 
egg consumption between men and women or across differ-
ent geographical areas may be associated with unmeasured 
lifestyle choices or in the context of different quality of the 
overall diet to motivate the differences observed in these 
strata, another hypothesis is that these strata may also reflect 
genetic unmeasured factors motivating the inter-individual 
variations. After the GRADE assessment, we could not 
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conclude that exist strong evidence of association between 
egg consumption and CVD outcomes, but higher quality 
studies showed a decreased risk of CVD for moderate intake 
of eggs (four per week), while higher risk of heart failure 
was found for higher intake of egg (one per day). Interpre-
tation of these findings is not easy: consuming up to four 
eggs per week may decrease the risk of CVD but increasing 
the intake to one egg per day or more may not be beneficial 
anymore. Nonetheless, we cannot exclude that the pattern 
of the diet and way of cooking might differ depending on 
the frequency of consumption (i.e., individuals with moder-
ate egg consumption may include eggs into specific recipes 
varying the way of cooking while habitual consumers may 
have fried eggs for breakfast together with bacon or other 
unhealthy dietary features). Such hypothesis could explain 
the different risks associated with egg consumption in West-
ern and Eastern Asian countries. This is a common issue 
for nearly all food groups when investigating the relation of 
one single dietary element with health. However, we cannot 
ignore that an association can be observed and, in that case, 
needs further attention.
There is a biological rationale to explain how moderate 
egg consumption might be associated to decreased risk of 
CVD. Eggs have been historically considered a controver-
sial food for nutritional experts and health agencies due to 
its content in cholesterol. However, researchers argue that 
the focus of common dietary guidelines on specific nutri-
ents (i.e., saturated fats) do not take into account that health 
effects varies depending on the specific food source [62]. 
Furthermore, the major attention paid to egg consump-
tion has been based on the assumption that higher dietary 
cholesterol intake would lead to rise in blood cholesterol, 
despite current evidence suggests otherwise [63, 64]. Recent 
meta-analyses showed rise of both LDL and HDL follow-
ing egg consumption in healthy individuals, with minimum 
rise of LDL:HDL ratio (marker of CVD risk) finally lead-
ing to no substantial increased risk profile [63, 64]. Thus, 
the concomitant rise of HDL cholesterol might counteract 
the elevation of LDL, while other components of egg might 
exert potential beneficial effects [65]. Eggs are a highly 
nutritious food providing quality proteins and supplying 
micronutrients, antioxidants, antimicrobials, accompanied 
with great culinary versatility, which may have potential 
benefits to overall health. Some egg proteins, such as phosvi-
tin, ovotransferrin and ovalbumin can inhibit lipid oxidation 
by binding to metal or scavenging free radical [66]. In addi-
tion to protein, eggs also contain a large number of active 
lipid components, such as unsaturated fatty acids, phospho-
lipids, choline, and carotenoids. Eggs are considered a valu-
able source of omega-3 polyunsaturated fatty acids, which 
have been considered to exert a number of health benefits, 
including CVD protection [67]. Eggs are a major source 
of choline, an essential nutrient with critical roles in sev-
eral biological processes including neuronal development, 
cell signaling, and lipid transport and metabolism [68]. Part 
of the choline may undergo conversion to trimethylamine 
by gut microbiota, which in turn is oxidized in the liver to 
trimethylamine-N-oxide (TMAO), agent associated with 
increased atherosclerosis in the coronary vasculature [69]. 
Double blinded clinical trial investigating the effect of 0 to 6 
egg yolks ingested for the breakfast demonstrated that con-
sumption of ≥ 2 eggs results in an increased formation of 
TMAO yet not accompanied by a rise in hsCRP and oxidized 
LDL levels [70]. Phospholipids contained in eggs, including 
phosphatidylcholine, phosphatidylethanolamine, lysophos-
phatidylcholine, sphingomyelin, and some neutral lipids in 
minor quantities, may have, among others, broad effects on 
cholesterol metabolism, HDL functions, and inflammation 
[71]. Egg yolks are also a dietary source of bioavailable 
xanthophyll carotenoids, such as lutein and zeaxanthin, that 
have been shown to exert potential benefits against inflam-
mation and oxidation during early development, childhood, 
and may have lifetime consequences in determining health 
or onset of major diseases in the adult life [72].
Despite the evidence reported, nearly all analyses showed 
substantial heterogeneity of results between studies, lead-
ing to a weakening of the evidence. We hypothesize that 
the certain inconsistency of the results may depend on 
the variability of response to dietary cholesterol between 
individuals and the overall dietary and lifestyle framework 
within populations and individuals. Despite the majority of 
population experience moderate to no difference in blood 
cholesterol following the intake of dietary cholesterol (con-
sequently described as “normal responders”), about a third 
Table 5  Certainty of evidence by GRADE criteria
a Despite better quality studies provided less heterogeneity across 
results
b The analyses showed no evidence for non-linearity of associations
CVD CHD Stroke Heart failure
No. of studies 17 (14) 24 (16) 22 (16) 6 (4)
Downgrade quality of 
evidence
 Risk of bias No No No No
 Inconsistency Yes Yes No No
 Indirectness No No No Yes
 Imprecision No No No No
 Publication Bias No No No No
Upgrade quality of 
evidence
 Large effect No No No No
 Plausible confounding Noa Noa No No
 Dose–response Yesb No Yesb Yesb
Overall quality of evi-
dence
Low Low Moderate Low
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of individuals suffer of an abnormal rise in circulating LDL 
cholesterol (thus described as “hyper responders”) as a result 
of an increase fractional absorption and/or endogenous cho-
lesterol synthesis in response to dietary cholesterol intake 
[73]. An abnormal response to dietary cholesterol has been 
hypothesized to depend on altered cholesterol transport 
due to decreased levels of apolipoprotein E and increased 
of apolipoprotein C-III [74, 75]. Some genes responsible 
for intestinal absorption and biliary secretion of cholesterol 
and phytosterols, such as expression of ATP-binding cassette 
(ABC) transporters G5 (ABCG5) and G8 (ABCG8) [76], 
have been proposed as candidates for better understanding 
of potential genetic influences on egg metabolism. These 
genetic variants might provide the rationale, at least in part, 
for the geographical and sex differences observed in this 
study: however, further studies are warranted to identify 
other genetic markers that may explain the observed vari-
ability in cholesterol absorption/production among the gen-
eral population.
The results of this meta-analysis on heart failure seems 
to provide indication of potential increased risk for habit-
ual consumption (one egg per day) despite this evidence 
was affected by some limitations, including the role of sex: 
while sex seems to act as confounding factor for CVD, 
the observed variation in the direction for risk heart fail-
ure (increased in men and decreased in women) may lead 
to consider sex as an effect modifier. The reasons for such 
finding is not clear. The role of cholesterol abnormalities 
and risk or worsening of heart failure is unknown; data on 
worsening heart failure and lipid moieties are now beginning 
to emerge but conclusions are far to be made [77]. The fact 
that heart failure was the only outcome potentially at higher 
risk following consumption of eggs suggests that alternative 
mechanisms could be responsible for the observed associa-
tion. Interpretation of these differences between sexes makes 
even harder to provide a rationale for this result: as suggested 
in the individual studies included in the meta-analysis, it 
may be possible that the observed difference between sexes 
may depend on the fact that men might be more sensitive 
to high consumption of eggs (or cholesterol) than women, 
or it could be mediated by uncontrolled risk factors asso-
ciated with egg consumption (i.e., bacon) occurring more 
in men than women. Another hypothesis is that individuals 
more sensible to dietary cholesterol presenting blood lipids 
abnormalities may be regular users of statins, which in turn 
are known to increase the risk of atherosclerosis and heart 
failure by promoting arteries calcification and inhibiting the 
biosynthesis of selenium containing proteins, respectively 
[78]: this might explain the mixed results for CHD risk and 
increased risk of heart failure.
Another concern regard the different risk estimates 
observed in diabetic individuals showing an increased risk 
of CVD associated with consumption of one egg per day, 
notably in the different direction than for the general popu-
lation. The increased risk of developing CVD among indi-
viduals with type 2 diabetes may be mainly attributed to the 
impaired cholesterol absorption and synthesis. Studies on 
type 2 diabetic patients with uncontrolled hyperglycemia 
showed higher cholesterol synthesis and plasma lipid con-
centrations [79], including total cholesterol and triglycer-
ide, suggesting unfavorable effects of egg consumption on 
lipid profiles and, consequently, CVD risk. The mechanism 
might be explained, at least partially, by a reduced plasma 
level of campesterol, a marker of cholesterol absorption, and 
increased plasma levels of lathosterol, a marker of choles-
terol synthesis among diabetic people [80]. Moreover, apoli-
poprotein E polymorphism has been associated with higher 
risk of diabetes, and thus diabetic individuals tend to have 
lower serum levels of apolipoptorein E and impaired lipid 
transport [81].
The findings reported in this study should be considered 
in light of some limitations. First, some analyses showed 
substantial heterogeneity: several reasons for such discrep-
ancy of results across studies have been aforementioned, 
but no firm explanation can be drafted at this moment due 
to lack of data. Second, we stratified the analyses testing the 
role of controlling for potential confounding factors known 
to be related to cardiovascular outcomes in the original stud-
ies and revealed the importance of conducting higher qual-
ity studies to observe a decreased risk of CVD associated 
with moderate egg consumption; however, we cannot rule 
out the possibility that residual or unmeasured confounding 
may persist. Third, time-related variables, including poten-
tial reverse causation (i.e., change in dietary intake due to 
diagnosed medical condition or disease), period of evalu-
ation (i.e., baseline assessment or repeated over time), or 
duration of egg intake have been not investigated. Finally, 
the GRADE system may not be the best suit for assessing 
evidence in nutritional epidemiology, as by definition it 
tends to underestimate the strength of the evidence due to 
the observational nature of the studies. However, it helps 
to have a clearer idea of which can be the strengths and 
weaknesses of the studies evaluated (i.e., results from better 
quality studies are less heterogeneous and tend to show a 
decreased risk of CVD for moderate egg consumption) and 
a guide for future investigations.
Conclusion
Given the inconsistency of current findings on egg consump-
tion and risk of CVD, future studies should improve the 
characterization of the population investigated, aiming to 
identify and remove genetic bias, such as the determinants 
of normal/hyper-response to dietary cholesterol. However, 
current evidence is not sufficient to address egg consumption 
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as unhealthy nor to generalize potential detrimental effects 
to the whole population. While waiting for better designed 
and more complete studies overcoming the aforementioned 
limitations and lack of information on genetic profile, there 
may be no need to discourage egg consumption at the popu-
lation level.
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